Overview
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Covers prior losses | |
| Loans and borrowings | $385,741 | |
| Merger or transformation | Yes | |
| Shares in other companies |
|
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 92 days for 2021).
- 202516/07/2026
- 202408/07/2025
- 202302/07/2024
- 202213/07/2023
- 202115/10/2022
- 202013/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board – the President of the Management Board independently or a commercial proxy independently; in the case of a multi-member management board – the President of the Management Board independently or two members of the management board jointly or a commercial proxy independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 101 | $13,641.27 | 90.991% | |
Others | 10 | $1,350.62 | 9.009% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Imar Investmentssp. z o.o. | 1,428,957.32 USD | 73.9343% |
Bank accounts
Registered as a VAT taxpayer on 2000-09-01.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,176$3,176 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,238$4,238 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,386$5,386 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2023-11-14 | Address change (Przyłęcka 26, 02-402, Warszawa → Ul. Stanisława Lencewicza 2a, 01-493, Warszawa) | |
| 2023-11-14 | Switch to PKD 2007 (8 PKD 1997 codes → 8 PKD 2007 codes) | |
| 2003-06-16 | Address change (Bukowińska 24/A, 02-703, Warszawa → Przyłęcka 26, 02-402, Warszawa) | |
| 2002-10-28 | Entered in the register |
FAQ
Last updated: 2026-07-16